series-c-plus
Stage
1
Investors
About
Prognoshealth provides integrated, harmonized clinical and genomic laboratory data to life sciences companies, enabling improved drug development, commercial analytics, and healthcare provider targeting.
Explore Prognoshealth's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.